Pathological triad of perioperative acute kidney injury: renal microcirculatory hypoxia, mitochondrial damage, and immuno-metabolic reprogramming - Report - MDSpire

Pathological triad of perioperative acute kidney injury: renal microcirculatory hypoxia, mitochondrial damage, and immuno-metabolic reprogramming

  • By

  • Shenghua Li

  • Xiyan Wei

  • Xudong Han

  • Jingli Wang

  • Na Li

  • Jing Liu

  • Meiling Zhang

  • June 8, 2026

  • 0 min

Share

Clinical Report: The Pathophysiological Triad of Acute Kidney Injury

Overview

Expand on the 'novel pathological triangle model' by briefly explaining its components: renal microcirculatory hypoxia, mitochondrial dysfunction, and immuno-metabolic alterations.

Background

Perioperative AKI is a significant complication that can lead to increased mortality and prolonged hospital stays following surgery. Traditional models focusing solely on systemic hemodynamics are inadequate, as they fail to account for local microcirculatory and metabolic disturbances that contribute to AKI. Understanding these mechanisms is crucial for improving patient outcomes and developing targeted interventions.

Data Highlights

Remove HTML tags and state that no numerical data is available in the source material.

Key Findings

Rephrase findings for clarity and ensure they are directly supported by the source material.

Clinical Implications

Clinicians should consider a multidimensional approach to assess renal microcirculation and tissue oxygenation in high-risk surgical patients. Implementing targeted interventions based on the identified AKI phenotype may improve outcomes and reduce the incidence of severe AKI.

Conclusion

A comprehensive understanding of the pathophysiological mechanisms underlying perioperative AKI is essential for developing effective prevention and treatment strategies. The proposed model offers a framework for future research and clinical practice.

Related Resources & Content

  1. Frontiers in Immunology, 2026 -- Complement in acute kidney injury: a convergent pathogenic pathway in multifactorial renal damage
  2. Intensive Care Medicine, 2011 -- Highlights from Intensive Care Medicine 2011: I. Nephrology, Epidemiology, Nutrition, Neurology, Ethical Considerations, and Experimental Research
  3. Intensive Care Medicine, 2023 -- A Worldwide Examination of Postoperative Acute Kidney Injury Following Major Surgical Procedures: Essential Findings and Concerning Outcomes
  4. KDIGO, 2026 -- KDIGO 2026 AKI/AKD Guideline Public Review Draft
  5. Intensive Care Medicine — Emerging Pharmacological Therapies for Acute Kidney Injury
  6. A preventive care strategy to reduce moderate or severe acute kidney injury after major surgery (BigpAK-2); a multinational, randomised clinical trial
  7. Topic

Original Source(s)

Related Content